Evidence map›Paper›PMID 28145454›Full record

ArticleScientific reports2017

Eugenol prevents amyloid formation of proteins and inhibits amyloid-induced hemolysis.

Kriti Dubey, Bibin G Anand, Dolat Singh Shekhawat, Karunakar Kar

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Amino Acid Based Self-assembled Nanostructures: Complex Structures from Remarkably Simple Building Blocks.ChemNanoMat : chemistry of nanomaterials for energy, biology and more · 2018
    Article
  13. Article
  14. Effects of a combination treatment of KD5040 andBMC complementary and alternative medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kriti DubeyDepartment of Biology, Indian Institute of Technology Jodhpur, Rajasthan, 342011 India.
Bibin G AnandDepartment of Biology, Indian Institute of Technology Jodhpur, Rajasthan, 342011 India.
Dolat Singh ShekhawatDepartment of Biology, Indian Institute of Technology Jodhpur, Rajasthan, 342011 India.
Karunakar KarDepartment of Biology, Indian Institute of Technology Jodhpur, Rajasthan, 342011 India.
Indian Institute of Technology Jodhpur · INJawaharlal Nehru University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eugenol has attracted considerable attention because of its potential for many pharmaceutical applications including anti-inflammatory, anti-tumorigenic and anti-oxidant properties. Here, we have investigated the effect of eugenol on amyloid formation of selected globular proteins. We find that both spontaneous and seed-induced aggregation processes of insulin and serum albumin (BSA) are significantly suppressed in the presence of eugenol. Isothermal titration calorimetric data predict a single binding site for eugenol-insulin complex confirming the affinity of eugenol for native soluble insulin species. We also find that eugenol suppresses amyloid-induced hemolysis. Our findings reveal the inherent ability of eugenol to stabilize native proteins and to delay the conversion of protein species of native conformation into β-sheet assembled mature fibrils, which seems to be crucial for its inhibitory effect.

Indexed as

AmyloidAmyloidogenic ProteinsAmyloidosisEugenolHemolysisHumansMicroscopy, Atomic ForceProtein AggregatesProtein Aggregation, PathologicalProtein BindingSpectrum AnalysisAmyloidAmyloidogenic ProteinsEugenolProtein Aggregates

Identifiers

PMID28145454
PMCPMC5286398
OpenAlexW2584306427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.